List of insiders holdings for ENANTA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| SAINTS CAPITAL GRANITE L.P. Saints Capital Granite LLC mRNA - Holdings LLC OBP (Adjunct) III - Holdings LLC OBP (Bermuda) III - Holdings LLC OBP III - Holdings LLC 10% Owner | 2014-02-13 15:24:51 | 1,656,575 0 | 1,656,575 | Form 13G |
| Luly Jay R. President and CEO | 2024-02-14 20:00:28 | 810,609 0 | 810,609 | Form 4 |
| Goldberg Marc E. Director | 2013-12-06 18:20:57 | 0 547,606 | 547,606 | Form 4 |
| Or Yat Sun Chief Scientific Officer | 2024-02-14 20:12:54 | 373,295 0 | 373,295 | Form 4 |
| Gardiner Nathaniel S. Chief Legal Officer | 2024-02-27 18:31:52 | 153,501 35,926 | 189,427 | Form 4 |
| Kowalsky Matthew Paul Chief Legal Officer | 2024-05-01 16:27:12 | 150,000 0 | 150,000 | Form 4 |
| MELLETT PAUL J Chief Fin. & Admin Officer | 2024-02-14 20:09:35 | 95,896 0 | 95,896 | Form 4 |
| Adda Nathalie Sr. VP & Chief Medical Officer | 2022-04-05 19:54:18 | 75,567 0 | 75,567 | Form 4 |
| Luu Brendan Chief Business Officer | 2024-02-14 20:23:37 | 39,083 0 | 39,083 | Form 4 |
| Kieffer Tara Lynn Chief Product Strategy Officer | 2024-06-17 20:38:39 | 32,341 0 | 32,341 | Form 4 |
| Rottinghaus Scott T. Chief Medical Officer | 2024-08-09 17:24:47 | 18,784 0 | 18,784 | Form 4 |
| Ocain Tim Senior Vice President | 2019-02-13 21:40:08 | 17,547 0 | 17,547 | Form 4 |
| CARTER BRUCE L A Director | 2024-03-08 17:12:41 | 15,700 0 | 15,700 | Form 4 |
| FOLETTA MARK G Director | 2024-03-08 17:15:54 | 15,700 0 | 15,700 | Form 4 |
| Hata Yujiro S Director | 2024-03-08 17:19:03 | 15,700 0 | 15,700 | Form 4 |
| Peterson Kristine Director | 2024-03-08 17:23:55 | 15,700 0 | 15,700 | Form 4 |
| Russell Lesley Director | 2024-03-08 17:27:40 | 15,700 0 | 15,700 | Form 4 |
| Vance Terry Director | 2024-03-08 17:30:24 | 15,700 0 | 15,700 | Form 4 |
| Golumbeski George Director | 2020-02-28 17:08:24 | 10,000 0 | 10,000 | Form 4 |
| AFTING ERNST-GUENTER Director | 2016-02-12 16:07:50 | 6,000 0 | 6,000 | Form 4 |
| Poorvin David Director | 2013-03-22 16:14:10 | 5,800 0 | 5,800 | Form 4 |
| Buckley Stephen Jr. Director | 2019-03-01 20:03:06 | 5,000 0 | 5,000 | Form 4 |
| Verdine Gregory L. Director | 2013-03-28 16:24:41 | 3,324 0 | 3,324 | Form 4 |
| TVM V LIFE SCIENCE VENTURES GMBH & CO KG TVM V Life Science Ventures Management GmbH & Co. KG TVM IV GMBH & CO KG TVM IV Management GmbH & Co. KG TVM MEDICAL VENTURES GMBH & CO KG TVM Capital GmbH Birner Hubert Fischer Stefan Goll Alexandra SCHUHSLER HELMUT 10% Owner | 2016-02-19 16:46:58 | 0 0 | 0 | Form 13G |
| SHIONOGI & CO LTD 10% Owner | 2020-02-13 10:33:02 | 0 0 | 0 | Form 13G |